[go: up one dir, main page]

HRP20020404B1 - Otopine koje sadrže epinastin - Google Patents

Otopine koje sadrže epinastin

Info

Publication number
HRP20020404B1
HRP20020404B1 HR20020404A HRP20020404A HRP20020404B1 HR P20020404 B1 HRP20020404 B1 HR P20020404B1 HR 20020404 A HR20020404 A HR 20020404A HR P20020404 A HRP20020404 A HR P20020404A HR P20020404 B1 HRP20020404 B1 HR P20020404B1
Authority
HR
Croatia
Prior art keywords
optionally
agents
solution
adjusting
epinastine
Prior art date
Application number
HR20020404A
Other languages
English (en)
Croatian (hr)
Inventor
Trach Volker
Duschler Gerold
Original Assignee
Boehringer Ingelheim International Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7928843&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20020404(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim International Gmbh filed Critical Boehringer Ingelheim International Gmbh
Publication of HRP20020404A2 publication Critical patent/HRP20020404A2/hr
Publication of HRP20020404B1 publication Critical patent/HRP20020404B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F01—MACHINES OR ENGINES IN GENERAL; ENGINE PLANTS IN GENERAL; STEAM ENGINES
    • F01L—CYCLICALLY OPERATING VALVES FOR MACHINES OR ENGINES
    • F01L9/00—Valve-gear or valve arrangements actuated non-mechanically
    • F01L9/20—Valve-gear or valve arrangements actuated non-mechanically by electric means
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T137/00—Fluid handling
    • Y10T137/0318—Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Detergent Compositions (AREA)
HR20020404A 1999-11-12 2000-10-14 Otopine koje sadrže epinastin HRP20020404B1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19954516A DE19954516A1 (de) 1999-11-12 1999-11-12 Epinastin-haltige Lösungen
PCT/EP2000/010122 WO2001035962A1 (de) 1999-11-12 2000-10-14 Epinastin-haltige lösungen

Publications (2)

Publication Number Publication Date
HRP20020404A2 HRP20020404A2 (en) 2004-08-31
HRP20020404B1 true HRP20020404B1 (hr) 2007-08-31

Family

ID=7928843

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20020404A HRP20020404B1 (hr) 1999-11-12 2000-10-14 Otopine koje sadrže epinastin

Country Status (40)

Country Link
US (6) US20030050303A1 (cs)
EP (1) EP1231920B1 (cs)
JP (1) JP2003514021A (cs)
KR (1) KR100758842B1 (cs)
CN (1) CN1292752C (cs)
AR (1) AR026424A1 (cs)
AT (1) ATE353218T1 (cs)
AU (2) AU784017B2 (cs)
BG (1) BG65775B1 (cs)
BR (1) BR0015477A (cs)
CA (1) CA2391076C (cs)
CO (1) CO5251448A1 (cs)
CY (1) CY1106375T1 (cs)
CZ (1) CZ302483B6 (cs)
DE (2) DE19954516A1 (cs)
DK (1) DK1231920T3 (cs)
EA (1) EA006937B1 (cs)
EE (1) EE05395B1 (cs)
ES (1) ES2281359T3 (cs)
HK (1) HK1052303B (cs)
HR (1) HRP20020404B1 (cs)
HU (1) HU229502B1 (cs)
IL (2) IL149501A0 (cs)
ME (1) MEP36708A (cs)
MX (1) MXPA02004556A (cs)
MY (1) MY130441A (cs)
NO (1) NO329417B1 (cs)
NZ (1) NZ519425A (cs)
PE (1) PE20010826A1 (cs)
PL (1) PL198879B1 (cs)
PT (1) PT1231920E (cs)
RS (1) RS50173B (cs)
SA (1) SA01210658B1 (cs)
SI (1) SI1231920T1 (cs)
SK (1) SK287343B6 (cs)
TR (1) TR200201270T2 (cs)
TW (1) TWI225401B (cs)
UA (1) UA74563C2 (cs)
WO (1) WO2001035962A1 (cs)
ZA (1) ZA200203683B (cs)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
BR0313175A (pt) * 2002-08-02 2005-06-14 Boehringer Ingelheim Int Formulações farmacêuticas compreendendo combinações de epinastina, pseudoefedrina e metilefedrina
EP1468696A1 (en) * 2003-04-17 2004-10-20 Boehringer Ingelheim International GmbH Combinations of epinastine and antiphlogisitcs as new pharmaceutical compositions for the treatment of skin diseases
US20040247686A1 (en) * 2003-04-04 2004-12-09 Boehringer Ingelheim International Gmbh Pharmaceutical compositions comprising epinastine for the treatment of skin diseases
US20060073172A1 (en) * 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
JP2009500397A (ja) * 2005-07-08 2009-01-08 千寿製薬株式会社 エピナスチンを含む眼科用経皮吸収型製剤
US7378082B1 (en) 2007-11-05 2008-05-27 Inspire Pharmaceuticals, Inc. Method for treating allergic rhinitis without adverse effects
US20080194544A1 (en) * 2007-02-08 2008-08-14 Ramesh Krishnamoorthy Aqueous formulations of epinastine for treating allergic rhinitis
WO2008098122A2 (en) * 2007-02-08 2008-08-14 Inspire Pharmaceuticals, Inc. Method for treating allergic rhinitis without adverse effects
EP2464387A4 (en) * 2009-08-12 2013-05-15 Seros Medical Llc DEUTERATED WATER SOLUTION AND RIBOFLAVIN FOR EXTENDED OXYGEN SINGULET LIFETIME IN THE TREATMENT OF OCULAR TISSUE AND METHOD OF USE
TWI544922B (zh) 2011-05-19 2016-08-11 愛爾康研究有限公司 高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物
EP2630952A1 (en) * 2012-02-23 2013-08-28 Novagali Pharma S.A. Self-preserved oil dispersions comprising boric acid
JP6373867B2 (ja) * 2012-12-19 2018-08-15 サルコード・バイオサイエンス・インコーポレイテッド Ｌｆａ−１阻害剤製剤
CN104491876A (zh) * 2014-12-23 2015-04-08 中国药科大学 含玻璃酸钠的依匹斯汀滴眼液及其制备方法
ITUB20153950A1 (it) * 2015-09-28 2017-03-28 Tred Srl Dispositivo nasale in grado di attivare il riflesso rino-palatale per l'igienizzazione rinofaringea
JP6134853B1 (ja) * 2016-10-28 2017-05-24 参天製薬株式会社 エピナスチン含有点眼液
JP6635974B2 (ja) * 2017-04-24 2020-01-29 参天製薬株式会社 エピナスチン含有点眼液
KR102766744B1 (ko) * 2017-05-01 2025-02-11 산텐 세이야꾸 가부시키가이샤 점안제
JP2019108320A (ja) * 2018-10-31 2019-07-04 参天製薬株式会社 ソフトコンタクトレンズの変質を抑制する眼科用組成物
JP7599838B2 (ja) * 2019-04-10 2024-12-16 参天製薬株式会社 エピナスチン又はその塩を含有する水性医薬組成物
JP6736752B2 (ja) * 2019-12-17 2020-08-05 参天製薬株式会社 エピナスチン含有点眼液
JP7118579B1 (ja) 2020-04-16 2022-08-16 参天製薬株式会社 エピナスチン又はその塩を含有する水性組成物
JP6963651B2 (ja) * 2020-04-16 2021-11-10 参天製薬株式会社 エピナスチン又はその塩を含有する水性組成物
JP2020169213A (ja) * 2020-07-15 2020-10-15 参天製薬株式会社 エピナスチン含有点眼液
JP7114668B2 (ja) * 2020-10-08 2022-08-08 参天製薬株式会社 エピナスチン又はその塩を含有する花粉破裂抑制剤
CN115448927A (zh) * 2022-10-20 2022-12-09 重庆瑞泊莱医药科技有限公司 一种氢溴酸依匹斯汀晶型ii及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US228359A (en) * 1880-06-01 jones
US151541A (en) * 1874-06-02 Improvement in hay-loaders
US8632A (en) * 1852-01-06 George hess
US203021A (en) * 1878-04-30 Improvement in side-bar wagons
US181478A (en) * 1876-08-22 Improvement in water-wheels
US215396A (en) * 1879-05-13 Improvement in loom-temples
US104017A (en) * 1870-06-07 Improvement in embroidering attachment for sewing-machines
DE3008944A1 (de) * 1980-03-08 1981-09-24 C.H. Boehringer Sohn, 6507 Ingelheim Dibenzimidazoazepine, ihre herstellung und verwendung
DE4102148A1 (de) * 1991-01-25 1992-07-30 Boehringer Ingelheim Kg Verfahren zur herstellung von 3-amino-9,13b-dihydro-1h-dibenz-(c,f)imidazol(1,5-a)azepin-hydrochlorid
US5668133A (en) * 1992-12-09 1997-09-16 Alcon Laboratories, Inc. Ophthalmic compositions comprising emedastine and methods for their use
AU721566B2 (en) * 1995-06-27 2000-07-06 Boehringer Ingelheim Kg New stable pharmaceutical preparation for producing propellant-free aerosols
DE19542281C2 (de) * 1995-11-14 1997-12-04 Boehringer Ingelheim Kg Verwendung von Epinastin für die Behandlung der Migräne
KR20000035846A (ko) * 1996-08-30 2000-06-26 교토 야쿠힝 고교 가부시키가이샤 앨러지성 피부염 치료제
US20030215396A1 (en) * 1999-09-15 2003-11-20 Boehringer Ingelheim Pharma Kg Method for the production of propellant gas-free aerosols from aqueous medicament preparations
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
EP0903151A1 (en) * 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
CN1376066A (zh) * 1999-11-18 2002-10-23 爱尔康公司 H1拮抗剂和安全类固醇的治疗眼病的用途
DE19958460A1 (de) * 1999-12-03 2001-06-07 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Epinastine-Hydrochlorid in der hochschmelzenden Kristallmodifikation
FR2803520B1 (fr) * 2000-01-12 2002-09-20 Ceva Sante Animale Procede pour augmenter la production d'oeufs et consolider la coquille des oeufs chez les volailles
US20020094345A1 (en) * 2000-10-06 2002-07-18 Sara Abelaira Pharmaceutical compositions containing epinastine and pseudoephedrine
US20020137764A1 (en) * 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
US20020151541A1 (en) * 2000-10-31 2002-10-17 Michel Pairet Pharmaceutical compositions containing tiotropium salts and antihistamines and their use
DE10119718A1 (de) * 2001-04-21 2002-10-31 Boehringer Ingelheim Pharma Verfahren zur kontinuierlichen Herstellung inhalierfähiger Arzneistoffe, Vorrichtung zur Durchführung des Verfahrens und nach diesem Verfahren hergestellter Arzneistoff
US7420602B2 (en) * 2001-05-29 2008-09-02 Samsung Semiconductor Israel R&D Center (Sirc) Cmos imager for cellular applications and methods of using such
US20030104017A1 (en) * 2001-10-26 2003-06-05 Boehringer Ingelheim International Gmbh Epinastine formulation for oral administration
EP1350512A1 (en) * 2002-04-03 2003-10-08 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations
US6863848B2 (en) * 2002-08-30 2005-03-08 Signet Armorlite, Inc. Methods for preparing composite photochromic ophthalmic lenses
JP2007145316A (ja) * 2005-10-27 2007-06-14 Nissan Motor Co Ltd 遮光装置とサンバイザーとサンルーフユニット

Also Published As

Publication number Publication date
DE50014041D1 (de) 2007-03-22
EA200200492A1 (ru) 2002-10-31
IL149501A (en) 2012-04-30
US20090239842A1 (en) 2009-09-24
JP2003514021A (ja) 2003-04-15
BG65775B1 (bg) 2009-11-30
US20030050303A1 (en) 2003-03-13
ZA200203683B (en) 2003-09-03
CZ302483B6 (cs) 2011-06-08
UA74563C2 (uk) 2006-01-16
PE20010826A1 (es) 2001-08-20
HK1052303B (zh) 2007-04-13
PL364028A1 (en) 2004-11-29
EE200200246A (et) 2003-06-16
AU1138101A (en) 2001-05-30
PL198879B1 (pl) 2008-07-31
US7429602B2 (en) 2008-09-30
NO20022201L (no) 2002-05-08
US20070197503A1 (en) 2007-08-23
CA2391076C (en) 2008-06-17
NZ519425A (en) 2004-04-30
EP1231920B1 (de) 2007-02-07
HRP20020404A2 (en) 2004-08-31
HUP0203773A2 (hu) 2003-03-28
US20070185082A1 (en) 2007-08-09
SK287343B6 (sk) 2010-07-07
WO2001035962A1 (de) 2001-05-25
AU2006201541A1 (en) 2006-05-11
CN1292752C (zh) 2007-01-03
ATE353218T1 (de) 2007-02-15
PT1231920E (pt) 2007-03-30
EA006937B1 (ru) 2006-06-30
DE19954516A1 (de) 2001-05-17
AR026424A1 (es) 2003-02-12
HUP0203773A3 (en) 2005-01-28
MEP36708A (en) 2011-02-10
CZ20021956A3 (cs) 2002-08-14
CO5251448A1 (es) 2003-02-28
YU33602A (sh) 2005-03-15
TR200201270T2 (tr) 2002-12-23
SA01210658B1 (ar) 2006-11-05
CN1390129A (zh) 2003-01-08
AU784017B2 (en) 2006-01-12
HU229502B1 (en) 2014-01-28
MY130441A (en) 2007-06-29
BG106681A (en) 2002-12-29
BR0015477A (pt) 2002-06-25
ES2281359T3 (es) 2007-10-01
KR20020050273A (ko) 2002-06-26
EP1231920A1 (de) 2002-08-21
RS50173B (sr) 2009-05-06
DK1231920T3 (da) 2007-04-10
NO20022201D0 (no) 2002-05-08
TWI225401B (en) 2004-12-21
HK1052303A1 (en) 2003-09-11
SI1231920T1 (sl) 2007-06-30
KR100758842B1 (ko) 2007-09-19
US20080009476A1 (en) 2008-01-10
EE05395B1 (et) 2011-04-15
IL149501A0 (en) 2002-11-10
SK8302002A3 (en) 2002-09-10
US20050288274A1 (en) 2005-12-29
MXPA02004556A (es) 2004-09-10
NO329417B1 (no) 2010-10-18
CY1106375T1 (el) 2011-10-12
CA2391076A1 (en) 2001-05-25

Similar Documents

Publication Publication Date Title
HRP20020404B1 (hr) Otopine koje sadrže epinastin
MEP10408A (en) Platinum derivative pharmaceutical formulations
UY27320A1 (es) Nuevas composiciones farmacéuticas
MXPA03006841A (es) 4-fluoro-n-indan-2-il-benzamida y su uso como producto farmaceutico.
CO5271759A1 (es) Formulacion en solucion que contiene una mezcla de disolventes
TR200401029T4 (tr) Asilfenil-üre türevleri, imalat yöntemleri ve ilaç maddesi olarak kullanımları
DK1487829T3 (da) Thiadizolylpiperazinderivater, der er nyttige til behandling eller forebyggelse af smerte
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
ES2063146T3 (es) Composiciones farmaceuticas que contienen acido n-(3,4-dimetoxicinamoil)-antranilico.
SE0100569D0 (sv) New compounds
ATE273033T1 (de) Stabilisierte ophthalmische wasserstoffperoxidlösung
SE0102055D0 (sv) New Compounds
HUP9801924A2 (hu) Nátrium/hidrogén-csere inhibitorokat és szív- és keringési zavarok kezelésére alkalmas hatóanyagokat tartalmazó gyógyszerkészítmény
RS52150B (en) PELLETS CONTAINING VENLAFAKSIN HYDROCHLORIDE
NO20051023L (no) Oral administrering av calcitonin
JP4849288B2 (ja) 点眼剤及び涙液膜の安定化剤
SE0102057D0 (sv) New Salts I
ES2197781B1 (es) Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno.
BR0015423A (pt) Análogos de ácido 15-hidroxieicosatetraenóico interrompidos por heteroátomo e métodos de uso
WO2013169560A1 (en) Compositions and methods for treating symptoms of inflammatory related conditions using a combination of an antihistamine and a stimulant
MXPA05008711A (es) Uso de r-10-hidroxi-10,11-dihidro-carbamazepina en dolor neuropatico.
PE20041022A1 (es) Formulaciones farmaceuticas que comprenden un nuevo agente enmascarante de la amargura
JP2012006962A (ja) 眼科用組成物
EP1297838A4 (en) PRALMORELIN-CONTAINED NOSE DROP PREPARATIONS
JP2005075735A (ja) オキシメタゾリン含有組成物

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20190926

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20201014